AQR Capital Management »

Rapport Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $613k 21k 29.70
2025-06-30 $193k 17k 11.37

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
Wal-Mart Stores (WMT)
Alphabet Cap Stk Cl A (GOOGL)
Verisign (VRSN)
Alphabet Cap Stk Cl C (GOOG)
Adobe Systems Incorporated (ADBE)
Arista Networks Com Shs (ANET)
Palantir Technologies Cl A (PLTR)
PNC Financial Services (PNC)

View all positions for AQR Capital Management

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics